Professional Documents
Culture Documents
Hemascreen 50T (0721221) Exp. (2023.11.30) HS-50 (9.17.2021)
Hemascreen 50T (0721221) Exp. (2023.11.30) HS-50 (9.17.2021)
CERTIFICATE OF ANALYSIS
The following product(s) have been manufactured in compliance with FDA'S current good manufacturing practice regulations for medical devices.
Do not substitute reagents from kits from other manufacturers. You may interchange slides & reagent from Immunostics hema-screen kits as long as the kit
components are within the expiration date. The results of the hema-screen test should be interpreted in light of other clinical and diagnostic results.
The above product has been processed in accordance with the FDA Quality System Regulations CFR 820 Title 21 & ISO 13485. It has been tested by Quality
Control and meets all final QC specifications. Each lot of hema-screen slides are tested for the established patterns of graded reactivity against a panel of human
blood diluted with known concentrations of hemoglobin. Immunostics, Inc. concludes that there is no risk to the safety, efficacy or performance of the product. This
product is released for distribution and is suitable for use as described in the technical insert until the stated expiration date.
We assure that the above product was assembled and tested according to specifications. No changes have been made to manufacturing specification, procedures, labeling, packaging, Quality
Control specifications or test methods without the prior knowledge and approval.